2021

1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

   Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390